Medical Hand Function Rehabilitation Robot Gloves segmentation by application distinguishes four primary use‑cases that collectively drive market volume. Stroke rehabilitation accounts for roughly 45 % of deployments, reflecting the high incidence of post‑stroke motor impairment and the clinical emphasis on early intensive hand therapy; this segment contributes the largest share of equipment sales and service contracts. Orthopedic injury recovery, representing about 30 % of the market, focuses on fracture, tendon, and ligament repair patients where controlled mobilization accelerates functional return, thereby generating steady demand for mid‑range glove models. Neurological disorder therapy, estimated at 15 % of total adoption, includes conditions such as Parkinson’s disease and multiple sclerosis, where repetitive, task‑specific training mitigates tremor and spasticity; this niche influences the development of adaptive control algorithms. Post‑surgical hand therapy comprises the remaining 10 %, targeting patients after tendon transfers or joint arthroplasty; its limited but high‑value purchases shape premium pricing tiers. Together, these application categories define the market taxonomy and allocate resources across product development, regulatory pathways, and reimbursement strategies.